_eso-he-baisakh-lyric-preview-1.jpg "এসো হে বৈশাখ। Eso he Baisakh (+Lyric) from esho he boishakh various Video Screenshot Preview 1")
Gallery_eso-he-baisakh-lyric-preview-3.jpg "এসো হে বৈশাখ। Eso he Baisakh (+Lyric) from esho he boishakh various Video Screenshot Preview 3")
Gallery_eso-he-baisakh-lyric-preview-hqdefault.jpg "এসো হে বৈশাখ। Eso he Baisakh (+Lyric) from esho he boishakh various Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 4 minutes 3 seconds
👁 View: 1.4M times
Play Audio:👁 View: 1.4M times
Description:
Sabyasachi Sarkar
Sabyasachi Sarkar
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_worlds-first-head-transplant-system-unveiled.webp "The world’s first head transplant system has been unveiled.<br/><br/>Neuroscience and biomedical engineering startup BrainBridge have announced a mind-bending concept that would allow a head to be grafted onto a donor body.<br/><br/>The futuristic system would offer new hope to patients suffering from untreatable conditions such as stage-4 cancer, paralysis, and neurodegenerative diseases like Alzheimer's and Parkinson's.<br/><br/>The whole-body procedure involves transplanting a patient's head onto a healthy, brain-dead donor body, ensuring the preservation of consciousness, memories, and cognitive abilities.<br/><br/>BrainBridge say the process aims to be available within 8 years and would integrate advanced robotics and artificial intelligence to carry out the transplantation procedures.<br/><br/>The company add they will also be able to conduct face and scalp transplantation to restore functionality and aesthetic appearance. <br/><br/>BrainBridge are recruiting and have listed roles for experts in several fields including brain computer interfaces (BCI), as seen in Elon Musk's Neuralink brain chip, robotic surgery and neuroscience.<br/><br/>The concept is the brainchild of Dubai-based project lead Hashem Al-Ghaili, a biotechnologist and science communicator.<br/><br/>He says: \")
_achena-boishakh-124-lyrical-124-various-artists.webp "Asha Audio")
_growing-number-of-americans-are-trying-weight-loss-drugs.webp "Growing , Number of Americans Are Trying , Weight-Loss Drugs.<br/>According to a recent poll, six percent of adults <br/>in the United States have already tried Ozempic <br/>or other brand name weight loss medications.<br/>According to a recent poll, six percent of adults <br/>in the United States have already tried Ozempic <br/>or other brand name weight loss medications.<br/>'Newsweek' reports that the Gallup poll numbers<br/>suggest that approximately 15.5 million Americans have <br/>used or are using an injectable diabetes medication. .<br/>'Newsweek' reports that the Gallup poll numbers<br/>suggest that approximately 15.5 million Americans have <br/>used or are using an injectable diabetes medication. .<br/>According to the poll, three percent <br/>of those users are specifically <br/>using the drug for weight loss.<br/>The poll found that people between the ages <br/>of 40 and 64 are the most likely to try Ozempic <br/>or competitors, like Wegovy or Saxenda. .<br/>In 2017, the U.S. Food and Drug <br/>Administration (FDA) approved Ozempic <br/>to treat cardiovascular disease and diabetes. .<br/>'Newsweek' reports that while Ozempic has <br/>not been approved for weight-loss purposes, <br/>its competitor Wegovy was approved in 2021. .<br/>'Newsweek' reports that while Ozempic has <br/>not been approved for weight-loss purposes, <br/>its competitor Wegovy was approved in 2021. .<br/>Both drugs rely upon the active ingredient <br/>semaglutide, however, Wegovy contains <br/>a higher amount than Ozempic.<br/>Both drugs rely upon the active ingredient <br/>semaglutide, however, Wegovy contains <br/>a higher amount than Ozempic.<br/>The popularity of the drug has resulted <br/>in various makers reporting shortages. .<br/>The drug companies didn't <br/>anticipate how popular <br/>these drugs would become, Sue Decotiis, Triple-board-certified medical <br/>weight-loss doctor in New York City, via 'Newsweek'.<br/>Since they are being used <br/>for many issues, like diabetes, <br/>heart failure, obesity, <br/>this exacerbates the <br/>shortages significantly, Sue Decotiis, Triple-board-certified medical <br/>weight-loss doctor in New York City, via 'Newsweek'")
_eso-he-boishakh-esho-esho-124-rabindra-sangeet-124-full-hd-video.webp "RDC Banglar Geeti")
_eso-hey-boisakh-124124-gaansongo-124124-jayati-chakraborty-124124-rabindransangeet.webp "Rana Banerjee")
⏲ 3 minutes 46 seconds 👁 985.5K
_tesla-shareholders-mount-opposition-to-elon-musk39s-3646b-pay-package-following-court-ruling.webp "A group of Tesla shareholders is urging investors to vote against Elon Musk's $46 billion pay package and the re-election of two board members at the upcoming shareholder meeting on June 13. The shareholder group argues that the board is too close to Musk and has failed to properly evaluate his compensation package, which was originally approved in 2018 but struck down by a Delaware court in January due to concerns about the approval process. Tesla has re-proposed the pay package, arguing that Musk earned the compensation by hitting targets related to the company's share price and operations. However, the shareholder group believes that Musk's divided attention among various companies exposes shareholders to unnecessary risk.")
⏲ 0:44 👁 4.7M
_worlds-first-head-transplant-system-unveiled.jpg)
_achena-boishakh-124-lyrical-124-various-artists.jpg)
_growing-number-of-americans-are-trying-weight-loss-drugs.jpg)
_eso-he-boishakh-esho-esho-124-rabindra-sangeet-124-full-hd-video.jpg)
_eso-hey-boisakh-124124-gaansongo-124124-jayati-chakraborty-124124-rabindransangeet.jpg)
_tesla-shareholders-mount-opposition-to-elon-musk39s-3646b-pay-package-following-court-ruling.jpg)
![[+]](/images/menu.gif){kind=small}